Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
30 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Genelux Corporation’s names, not what it holds today.
Patents granted
30
30 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
5
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'09'10'11'12'13'14'15'16'17'18'19'20'21'23'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Genelux Corporation its own name
US, as the owner printed on each patent
0 publishedGENELUX CORPORATION its own name
named as the applicant on its applications, in US
5 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jun 24, 2025 | 12,338,464 | Clonal strains of attenuated vaccinia viruses and methods of use thereof | Pharmaceuticals | Genelux Corporation |
| Oct 19, 2021 | 11,149,254 | Clonal strains of attenuated vaccinia viruses and methods of use thereof | Pharmaceuticals | Genelux Corporation |
| Dec 1, 2020 | 10,851,350 | Bioreactor production of virus from adherent cells | Biotechnology | Genelux Corporation |
| Mar 10, 2020 | 10,584,317 | Modified vaccinia virus strains for use in diagnostic and therapeutic methods | Pharmaceuticals | Genelux Corporation |
| Nov 5, 2019 | 10,463,730 | Microorganisms for therapy | Pharmaceuticals | Genelux Corporation |
| Mar 26, 2019 | 10,238,700 | Oncolytic virus adjunct therapy with agents that increase virus infectivity | Pharmaceuticals | Genelux Corporation |
| Apr 17, 2018 | 9,944,903 | Modified vaccinia virus strains for use in diagnostic and therapeutic methods | Pharmaceuticals | Genelux Corporation |
| Nov 15, 2016 | 9,492,534 | Microorganisms for therapy | Pharmaceuticals | Genelux Corporation |
| Apr 14, 2015 | 9,005,602 | Modified vaccinia virus strains for use in diagnostic and therapeutic methods | Pharmaceuticals | Genelux Corporation |
| Oct 21, 2014 | 8,865,153 | Microorganisms for imaging and/or treatment of tumors | Pharmaceuticals | Genelux Corporation |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jan 12, 2023 | 2023/0008052 | CLONAL STRAINS OF ATTENUATED VACCINIA VIRUSES AND METHODS OF USE THEREOF | Pharmaceuticals | GENELUX CORPORATION · patent 12,338,464 granted from it |
| Jul 12, 2018 | 2018/0195050 | MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS | Pharmaceuticals | GENELUX CORPORATION · patent 10,584,317 granted from it |
| Apr 6, 2017 | 2017/0095552 | MICROORGANISMS FOR THERAPY | Pharmaceuticals | GENELUX CORPORATION · patent 10,463,730 granted from it |
| Nov 24, 2016 | 2016/0339066 | ONCOLYTIC VIRUS ADJUNCT THERAPY WITH AGENTS THAT INCREASE VIRUS INFECTIVITY | Pharmaceuticals | GENELUX CORPORATION · patent 10,238,700 granted from it |
| Jun 25, 2015 | 2015/0175976 | MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS | Pharmaceuticals | GENELUX CORPORATION · patent 9,944,903 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.